Berdeja Compares Later-Line Therapies in Multiple Myeloma
Berdeja Compares Later-Line Therapies in Multiple Myeloma As part of a virtual Case Based Peer Perspective event, Jesus G. Berdeja, MC, director of Myeloma Research, Sarah Cannon Research Institute, in Nashville, Tennesee, discussed the treatment options for stage II multilple myeloma, based on a case of a 71-year female patient. Targeted Oncology™: Is this patient […]
Read More